T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Amazon
AMZN
|
+$3.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.02B |
| 3 |
EQT Corp
EQT
|
+$1.52B |
| 4 |
Adobe
ADBE
|
+$1.29B |
| 5 |
Constellation Energy
CEG
|
+$1.16B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.09B |
| 2 |
UnitedHealth
UNH
|
+$1.75B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.69B |
| 4 |
Ross Stores
ROST
|
+$1.64B |
| 5 |
ASML
ASML
|
+$1.59B |
Sector Composition
| 1 | Technology | 31.66% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBA
851
DELISTED
Walgreens Boots Alliance
WBA
| $27.2M | ﹤0.01% |
955,605
-8,835
| -0.9% | -$252K |
|
852
ICU Medical
ICUI
$3.33B
| $27.2M | ﹤0.01% |
152,516
-14,596
| -9% | -$2.6M |
|
853
Iron Mountain
IRM
$29.2B
| $27M | ﹤0.01% |
475,549
+1,678
| +0.4% | +$95.3K |
|
|
ARCE
854
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
| $26.7M | ﹤0.01% |
2,203,118
-16,400
| -0.7% | -$199K |
|
855
Monte Rosa Therapeutics
GLUE
$302M
| $26.7M | ﹤0.01% |
3,896,498
+203,004
| +5% | +$1.39M |
|
856
Invitation Homes
INVH
$18.8B
| $26.6M | ﹤0.01% |
774,542
+2,216
| +0.3% | +$76.2K |
|
857
Allogene Therapeutics
ALLO
$260M
| $26.5M | ﹤0.01% |
5,331,400
-998,904
| -16% | -$4.96M |
|
858
Brown & Brown
BRO
$31.1B
| $26.3M | ﹤0.01% |
382,587
-3,318,277
| -90% | -$228M |
|
859
Grupo Aeroportuario del Sureste
ASR
$10.4B
| $26.3M | ﹤0.01% |
94,601
-660
| -0.7% | -$183K |
|
860
Tenaya Therapeutics
TNYA
$209M
| $26.2M | ﹤0.01% |
4,469,641
+82,858
| +2% | +$486K |
|
861
Graco
GGG
$14.3B
| $26.1M | ﹤0.01% |
302,450
-41,461
| -12% | -$3.58M |
|
862
PPL Corp
PPL
$26.6B
| $26.1M | ﹤0.01% |
986,764
-619
| -0.1% | -$16.4K |
|
863
Morningstar
MORN
$10.8B
| $26M | ﹤0.01% |
132,583
+101,381
| +325% | +$19.9M |
|
864
Pebblebrook Hotel Trust
PEB
$1.4B
| $26M | ﹤0.01% |
1,862,784
-980,830
| -34% | -$13.7M |
|
865
Lyell Immunopharma
LYEL
$256M
| $26M | ﹤0.01% |
408,055
+209,688
| +106% | +$13.3M |
|
866
Iovance Biotherapeutics
IOVA
$876M
| $25.8M | ﹤0.01% |
3,663,373
-92,495
| -2% | -$651K |
|
867
Evolent Health
EVH
$1.08B
| $25.8M | ﹤0.01% |
850,261
+6,317
| +0.7% | +$191K |
|
868
Crinetics Pharmaceuticals
CRNX
$3.18B
| $25.8M | ﹤0.01% |
1,428,910
+1,387,127
| +3,320% | +$25M |
|
869
Sapiens International
SPNS
$2.4B
| $25.7M | ﹤0.01% |
965,712
-43,539
| -4% | -$1.16M |
|
870
Pultegroup
PHM
$27.4B
| $25.6M | ﹤0.01% |
329,220
-26
| -0% | -$2.02K |
|
871
Allegion
ALLE
$15.2B
| $25.3M | ﹤0.01% |
211,136
+20,528
| +11% | +$2.46M |
|
|
FTCH
872
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $25.3M | ﹤0.01% |
4,187,178
-2,685,950
| -39% | -$16.2M |
|
873
Skyward Specialty Insurance
SKWD
$1.93B
| $25.2M | ﹤0.01% |
992,204
-238,245
| -19% | -$6.05M |
|
874
Carnival Corp
CCL
$44B
| $25.1M | ﹤0.01% |
1,335,443
+3,842
| +0.3% | +$72.3K |
|
875
A.O. Smith
AOS
$10.4B
| $25.1M | ﹤0.01% |
344,999
-12,559
| -4% | -$914K |
|